Publications by authors named "John Burfeind"

Claim this Profile
E
Evaluation and management of incomplete ovarian function suppression in premenopausal breast cancer patients receiving anti-hormone therapy.
Ruchi Patel, Elizabeth Weil, Sara Bugamelli, Emma Carroll, Kylie Steinke, John Burfeind

Breast Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection.
Michael Pierro, Joanna Zurko, Anika Szabo, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind

WMJ· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy.
Lubna N Chaudhary, Julie M Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind

Breast Cancer Res Treat· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy.
Lubna Naaz Chaudhary, Julie Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind

Res Sq· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study.
Nithya Sridhar, Chad Glisch, Zeeshan Jawa, Lubna N Chaudhary, Sailaja Kamaraju, John Burfeind

J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial.
William A Hall, Meena Bedi, Deepak Kilari, Kathryn A Bylow, John Burfeind

Pract Radiat Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm.
Ruben Raychaudhuri, Matthew J Riese, Kathryn Bylow, John Burfeind, Alexander C Mackinnon

Clin Genitourin Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis